Dolby Family Ventures is a San Francisco-based venture capital firm that invests in early-stage companies solving complex scientific and engineering problems. The fund has developed a meaningful presence in neuroscience and precision health through a combination of capital, scientific guidance, and long-term support.

Its portfolio includes companies such as Cerevance and Motif Neurotech, demonstrating direct activity in CNS therapeutics and neuromodulation. A key differentiator is its scientific advisory depth, which allows it to engage seriously with technically demanding companies in neuro and brain health.

The fund invests internationally, with strongest activity in North America and Europe. It is especially relevant for neurotech startups looking for patient capital and investors with the ability to understand both device and biology-heavy approaches.